✦ LIBER ✦

Primary tumour–vessel tumour–nodal tumour classification for patients with invasive ductal carcinoma of the breast

✍ Scribed by Hasebe, T; Sasaki, S; Imoto, S; Wada, N; Ishii, G; Ochiai, A

Book ID: 109998384
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 167 KB
Volume: 92
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602353

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Residual tumour after biopsy for non-pal

Residual tumour after biopsy for non-palpable ductal carcinoma in situ of the breast

✍ Dr Th. Wobbes; J. G. M. Tinnemans; R. F. van der Sluis 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 2 views

Loss of CSMD1 expression is associated w

Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma

✍ Mohamed Kamal; Abeer M. Shaaban; Liqun Zhang; Clare Walker; Sally Gray; Nalin Th 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 445 KB

The expression pattern of MUC1 (EMA) is

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma

✍ B Van Der Vegt; M A J De Roos; J L Peterse; C Patriarca; J Hilkens; G H De Bock; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

Significance of nodal metastatic tumor c

Significance of nodal metastatic tumor characteristics in nodal metastasis and prognosis of patients with invasive ductal carcinoma of the breast

✍ Takahiro Hasebe; Satoshi Sasaki; Shigeru Imoto; Atsushi Ochiai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

The value of tumour marker kinetics in t

The value of tumour marker kinetics in the management of patients with primary hepatocellular carcinoma

✍ Dr. P. K. Buamah; O. F. W. James; A. W. Skillen; A. L. Harris 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Serum alpha-fetoprotein (AFP) has been measured during chemotherapy of ten patients with hepatocellular carcinoma. Whenever the AFP concentration of a sample was lower than that of the previous sample the apparent half-life (AHL) of the protein was calculated. The biological half-life of AFP is 5 da

Bilateral apocrine carcinoma of the brea

Bilateral apocrine carcinoma of the breast Molecular and immunocytochemical evidence for two independent primary tumours

✍ F. C. Schmitt; Raquel Soares; Raquel Seruca 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 190 KB